Glooko continues to carve out a niche in the mobile diabetes management space.
Search Results for: node/Roche Diagnostics
ATON Partners, the newly formed brainchild of a pair of former women’s healthcare executives, plans to provide advisory services to medical device and in vitro diagnostics companies in early development.
Launched by Patrick Sullivan and Daniel Levangie, a former MassDevice winner for most innovative medtech CEOs, ATON is also looking for investment opportunities in medtech and product development.
Silicon Valley mHealth company Glooko is rocketing forward in the mobile diabetes management space since its inception less than 3 years ago, boasting multiple FDA clearances, wide-ranging industry partnerships and a growing base of patient users and healthcare provider subscribers.
Just last month, Glooko won FDA clearance for the 2nd generation of its iPhone diabetes management app and launched the 1st subscriber portal at San Diego’s Scripps Whittier Diabetes Institute.
Biotech titan Roche acquired Boston, Mass.-based medical device company Constitutional Medical Investors for a reported $220 million plus possible milestones.